These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 21540109)

  • 1. P-glycoprotein limits the absorption of the anti-HIV drug zidovudine through rat intestinal segments.
    Quevedo MA; Nieto LE; Briñón MC
    Eur J Pharm Sci; 2011 Jun; 43(3):151-9. PubMed ID: 21540109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intestinal permeability of lamivudine (3TC) and two novel 3TC prodrugs. Experimental and theoretical analyses.
    Gualdesi MS; Briñón MC; Quevedo MA
    Eur J Pharm Sci; 2012 Dec; 47(5):965-78. PubMed ID: 23072916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo pharmacokinetic characterization of two novel prodrugs of zidovudine.
    Quevedo MA; Briñón MC
    Antiviral Res; 2009 Aug; 83(2):103-11. PubMed ID: 19549583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Segmental dependent transport of low permeability compounds along the small intestine due to P-glycoprotein: the role of efflux transport in the oral absorption of BCS class III drugs.
    Dahan A; Amidon GL
    Mol Pharm; 2009; 6(1):19-28. PubMed ID: 19248230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scaling of in vitro membrane permeability to predict P-glycoprotein-mediated drug absorption in vivo.
    Shirasaka Y; Masaoka Y; Kataoka M; Sakuma S; Yamashita S
    Drug Metab Dispos; 2008 May; 36(5):916-22. PubMed ID: 18276834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple efflux pumps are involved in the transepithelial transport of colchicine: combined effect of p-glycoprotein and multidrug resistance-associated protein 2 leads to decreased intestinal absorption throughout the entire small intestine.
    Dahan A; Sabit H; Amidon GL
    Drug Metab Dispos; 2009 Oct; 37(10):2028-36. PubMed ID: 19589874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Permeability dominates in vivo intestinal absorption of P-gp substrate with high solubility and high permeability.
    Cao X; Yu LX; Barbaciru C; Landowski CP; Shin HC; Gibbs S; Miller HA; Amidon GL; Sun D
    Mol Pharm; 2005; 2(4):329-40. PubMed ID: 16053336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. pH-dependent functional activity of P-glycoprotein in limiting intestinal absorption of protic drugs: kinetic analysis of quinidine efflux in situ.
    Varma MV; Panchagnula R
    J Pharm Sci; 2005 Dec; 94(12):2632-43. PubMed ID: 16258992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-treatment with grapefruit juice inhibits while chronic administration activates intestinal P-glycoprotein-mediated drug efflux.
    Panchagnula R; Bansal T; Varma MV; Kaul CL
    Pharmazie; 2005 Dec; 60(12):922-7. PubMed ID: 16398269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. P-glycoprotein is responsible for the poor intestinal absorption and low toxicity of oral aconitine: in vitro, in situ, in vivo and in silico studies.
    Yang C; Zhang T; Li Z; Xu L; Liu F; Ruan J; Liu K; Zhang Z
    Toxicol Appl Pharmacol; 2013 Dec; 273(3):561-8. PubMed ID: 24120885
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the permeability and P-glycoprotein efflux of carbamazepine and several derivatives across mouse small intestine by the Ussing chamber technique.
    Fortuna A; Alves G; Falcão A; Soares-da-Silva P
    Epilepsia; 2012 Mar; 53(3):529-38. PubMed ID: 22372629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transport of rhodamine 123, a P-glycoprotein substrate, across rat intestine and Caco-2 cell monolayers in the presence of cytochrome P-450 3A-related compounds.
    Yumoto R; Murakami T; Nakamoto Y; Hasegawa R; Nagai J; Takano M
    J Pharmacol Exp Ther; 1999 Apr; 289(1):149-55. PubMed ID: 10086998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In situ kinetic modelling of intestinal efflux in rats: functional characterization of segmental differences and correlation with in vitro results.
    González-Alvarez I; Fernández-Teruel C; Casabó-Alós VG; Garrigues TM; Polli JE; Ruiz-García A; Bermejo M
    Biopharm Drug Dispos; 2007 Jul; 28(5):229-39. PubMed ID: 17410527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral bioavailability and intestinal secretion of amitriptyline: Role of P-glycoprotein?
    Abaut AY; Chevanne F; Le Corre P
    Int J Pharm; 2007 Feb; 330(1-2):121-8. PubMed ID: 17092666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polarized efflux of mono- and diacid metabolites of ME3229, an ester-type prodrug of a glycoprotein IIb/IIIa receptor antagonist, in rat small intestine.
    Okudaira N; Komiya I; Sugiyama Y
    J Pharmacol Exp Ther; 2000 Nov; 295(2):717-23. PubMed ID: 11046110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of compartmental modeling to an examination of in vitro intestinal permeability data: assessing the impact of tissue uptake, P-glycoprotein, and CYP3A.
    Johnson BM; Charman WN; Porter CJ
    Drug Metab Dispos; 2003 Sep; 31(9):1151-60. PubMed ID: 12920171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of intestinal absorption of vitexin-2''-o-rhamnoside in hawthorn leaves flavonoids in rat using in situ and in vitro absorption models.
    Xu YA; Fan G; Gao S; Hong Z
    Drug Dev Ind Pharm; 2008 Feb; 34(2):164-70. PubMed ID: 18302035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetic profiling of P-glycoprotein-mediated drug efflux in rat and human intestinal epithelia.
    Stephens RH; O'Neill CA; Warhurst A; Carlson GL; Rowland M; Warhurst G
    J Pharmacol Exp Ther; 2001 Feb; 296(2):584-91. PubMed ID: 11160647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study on in situ and in vivo absorption kinetics of phenytoin by modulating P-glycoprotein with verapamil in rats.
    Neerati P; Ganji D; Bedada SK
    Eur J Pharm Sci; 2011 Sep; 44(1-2):27-31. PubMed ID: 21640186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional role of P-glycoprotein in limiting intestinal absorption of drugs: contribution of passive permeability to P-glycoprotein mediated efflux transport.
    Varma MV; Sateesh K; Panchagnula R
    Mol Pharm; 2005; 2(1):12-21. PubMed ID: 15804173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.